Search

Richard V Smerbeck

from Pittsford, NY
Age ~67
Get Report
Also known as:
Richard Vincent Smerbeck, Dick V Smerbeck, Rick V Smerbeck, Richd Smerbeck, Merbe S Richard
Phone and address:
42 Kirklees Rd, Pittsford, NY 14534
(585) 348-9744
Related to:
Kierstin Smerbeck, 28Jon C Svoboda, 53Von C SvobodaKevin Smerbeck, 31Elizabeth G Svoboda, 47Rudolph J Svoboda, 80Margaret G Smerbeck, 63Dennis J Smerbeck, 53
Connected to:
Haley M Smerchek, 42Scott A Smerchek, 37Ian M Smercina, 34Rachel M Smerd, 51Anthony Smerdel, 75Robert J Smerdon, 54Wayne W Smerdon, 59Kenneth J Smerecki, 50Peter J Smerecki, 54Christine A Smerek, 46

Richard Smerbeck Phones & Addresses

  • 42 Kirklees Rd, Pittsford, NY 14534 (585) 348-9744
  • Rochester, NY
  • 1811 Hayden Rd, Germantown, TN 38138
  • 42 Kirklees Rd, Pittsford, NY 14534

Work

Company: Dawnbreaker, inc. Jan 2008 Position: Business acceleration manager

Education

Degree: BS School / High School: Duquesne University 1975 to 1980 Specialities: Biology

Skills

Technology Transfer • Cross Functional Team Leadership • Commercialization • Product Development • Start Ups • Fda • Business Strategy • Strategy • Management • Patents • Process Improvement • Medical Devices • R&D • Product Launch • Competitive Intelligence • Strategic Planning • Business Planning • Data Analysis • Proposal Writing • Program Management • Product Management • Competitive Analysis • Regulatory Affairs • Validation • Business Development • Project Management • Biotechnology • Market Research • Clinical Trials • Product Marketing • Pharmaceutical Industry • Research and Development • U.s. Food and Drug Administration

Industries

Management Consulting

Resumes

Resumes

Richard Smerbeck Photo 1

Richard Smerbeck

View page
Location:
Rochester, NY
Industry:
Management Consulting
Work:
Dawnbreaker, Inc. since Jan 2008
Business Acceleration Manager
RVS Pharmaceutical R&D Consulting Mar 2005 - Dec 2007
Principal
Bausch & Lomb 1995 - 2005
Vice President Global Pharmaceutical R&D
Schering-Plough Pharmaceuticals 1986 - 1995
Prinicipal Scientist
Warner Lambert - Morris Plains, NJ 1982 - 1986
Scientist
Education:
Duquesne University 1975 - 1980
BS, Biology
Skills:
Technology Transfer
Cross Functional Team Leadership
Commercialization
Product Development
Start Ups
Fda
Business Strategy
Strategy
Management
Patents
Process Improvement
Medical Devices
R&D
Product Launch
Competitive Intelligence
Strategic Planning
Business Planning
Data Analysis
Proposal Writing
Program Management
Product Management
Competitive Analysis
Regulatory Affairs
Validation
Business Development
Project Management
Biotechnology
Market Research
Clinical Trials
Product Marketing
Pharmaceutical Industry
Research and Development
U.s. Food and Drug Administration

Business Records

Name / Title
Company / Classification
Phones & Addresses
Richard Smerbeck
DAWNBREAKER, INC
Management Consulting Services · Accountant
2117 Buffalo Rd, Rochester, NY 14624
2338 W Royal Palm Rd STE -J, Phoenix, AZ 85021
3161 Un St, North Chili, NY 14514
(585) 594-0025, (585) 264-0510, (585) 594-8623, (585) 594-5099

Publications

Us Patents

Method For Treating Dry Eye

View page
US Patent:
6348508, Feb 19, 2002
Filed:
Apr 4, 2000
Appl. No.:
09/542332
Inventors:
John Denick, Jr. - Pittsford NY
David J. Heiler - Avon NY
Zhenze Hu - Pittsford NY
Joseph C. Salamone - Boca Raton FL
Richard V. Smerbeck - Pittsford NY
Assignee:
Bausch Lomb Incorporated - Rochester NY
International Classification:
A61K 4732
US Classification:
5147724, 424427, 424434, 424435, 424 7804
Abstract:
The present invention is directed to a method of treating dry eye by instilling eyedrops of a composition containing a cationic cellulosic polymer. Such compositions have been found to alleviate the symptoms of dry eye without requiring the presence of anionic therapeutic agents. Low ionic strength solutions are particularly preferred.

Composition And Method For Inhibiting Uptake Of Biguanide Disinfectants By Poly(Ethylene)

View page
US Patent:
6514528, Feb 4, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/916455
Inventors:
Erning Xia - Pittsford NY
Richard V. Smerbeck - Pittsford NY
John Denick, Jr. - Pittsford NY
Assignee:
Bausch Lomb Incorporated - Rochester NY
International Classification:
A61K 920
US Classification:
424464, 424 7804
Abstract:
The invention provides a method for inhibiting the binding of a biguanide disinfectant in aqueous solution to a poly(ethylene) solid in contact with said solution comprising providing in said solution an amount of cyclodextrin sufficient to inhibit binding of the biguanide disinfectant to the poly(ethylene) solid.

Composition And Method For Inhibiting Uptake Of Biguanide Antimicrobials By Hydrogels

View page
US Patent:
6528464, Mar 4, 2003
Filed:
Aug 17, 2001
Appl. No.:
09/932356
Inventors:
Erning Xia - Penfield NY
Richard V. Smerbeck - Pittsford NY
Rebecca Franklin - Rochester NY
Assignee:
Bausch Lomb Incorporated - Rochester NY
International Classification:
C11D 348
US Classification:
510112, 510113, 510114, 510382, 514839, 514840
Abstract:
The invention provides a method for inhibiting the binding of a biguanide antimicrobial in aqueous solution to a hydrogel in contact with said solution comprising providing in said solution an amount of cyclodextrin sufficient to inhibit sorption of the biguanide antimicrobial to a hydrogel.

Reversible Gelling System For Ocular Drug Delivery

View page
US Patent:
6703039, Mar 9, 2004
Filed:
Dec 6, 2000
Appl. No.:
09/731290
Inventors:
Erning Xia - Penfield NY
Richard V. Smerbeck - Pittsford NY
Assignee:
Bausch Lomb Incorporated - Rochester NY
International Classification:
A61F 200
US Classification:
424427, 424422, 424484, 424486, 424488, 424 7817, 5147721
Abstract:
The invention provides an ophthalmic aqueous composition for topical administration, comprising: (a) a block copolymer of propylene oxide and ethylene oxide in concentration sufficient to provide viscosity of less than about 25 centipoise at ambient temperature and viscosity of from about 25 to about 55 centipoise when applied topically to a patient; (b) hydroxypropyl methylcellulose in concentration sufficient to improve the durability of the gel formed by the block copolymer. The invention further provides a method for administering ophthalmic pharmaceuticals.

Method For Enhancing Integrity Of Epithelium Using Retinoic Acid

View page
US Patent:
6787131, Sep 7, 2004
Filed:
Dec 17, 2001
Appl. No.:
10/023351
Inventors:
Andrea M. Lever - Pittsford NY
Richard V. Smerbeck - Pittsford NY
Joseph C. Salamone - Boca Raton FL
Assignee:
Bausch Lomb Incorporated - Rochester NY
International Classification:
A61K 3174
US Classification:
424 7804, 424427, 424429
Abstract:
A method for improving the integrity of the corneal epithelium by introducing into the eye an effective amount of a ophthalmically compatible retinoid sufficient to enhance the integrity of the corneal epithelium.

Method For Enhancing Integrity Of Epithelium Using Retinoic Acid

View page
US Patent:
7087222, Aug 8, 2006
Filed:
Jun 16, 2004
Appl. No.:
10/869432
Inventors:
Andrea M. Lever - Pittsford NY, US
Richard V. Smerbeck - Pittsford NY, US
Joseph C. Salamone - Boca Raton FL, US
Assignee:
Bausch & Lomb Incorporated - Rochester NY
International Classification:
A61K 31/74
A61F 2/14
US Classification:
424 7804, 424427, 424428
Abstract:
A method for improving the integrity of the corneal epithelium by introducing into the eye an effective amount of a ophthalmically compatible retinoid sufficient to enhance the integrity of the corneal epithelium.

Surface Treatment Of Non-Plasma Treated Silicone Hydrogel Contact Lenses

View page
US Patent:
20020182315, Dec 5, 2002
Filed:
May 7, 2002
Appl. No.:
10/140600
Inventors:
David Heiler - Avon NY, US
Lisa Simpson - Rochester NY, US
John Denick - Pittsford NY, US
Suzanne Groemminger - Rochester NY, US
Richard Smerbeck - Pittsford NY, US
International Classification:
B05D005/06
B05D003/02
B05D001/18
US Classification:
427/162000, 427/387000, 427/430100
Abstract:
The present invention provides an optically clear, hydrophilic coating upon the surface of a non-plasma treated hydrophobic hydrogel lens by heating the lens in an aqueous solution containing a surface-protective agent. Alternately, the non-plasma treated hydrophobic hydrogel lens may be subjected to ultrasonication while immersed in an aqueous solution containing a surface-protective agent.

Composition And Method For Inhibiting Uptake Of Biguanide Antimicrobials By Hydrogels

View page
US Patent:
20030096717, May 22, 2003
Filed:
Nov 5, 2002
Appl. No.:
10/288637
Inventors:
Erning Xia - Penfield NY, US
Richard Smerbeck - Pittsford NY, US
Rebecca Franklin - Webster NY, US
Assignee:
Bausch & Lomb Incorporated - Rochester NY
International Classification:
C11D001/00
US Classification:
510/112000
Abstract:
The invention provides a method for inhibiting the binding of a biguanide antimicrobial in aqueous solution to a hydrogel in contact with said solution comprising providing in said solution an amount of cyclodextrin sufficient to inhibit sorption of the biguanide antimicrobial to a hydrogel.
Control profile
Richard V Smerbeck from Pittsford, NY, age ~67 Get Report